Splose, an Adelaide, Australia-based AI-enabled practice management platform for Allied Health professionals, has raised AUD $46 million in Series A funding.
Investors
The round was led by Spectrum Equity, with participation from Athletic Ventures and continued support from EVP.
Spectrum Equity is a growth equity investment firm founded in 1994 that partners with software, data, and consumer internet companies to accelerate their expansion through capital and strategic support. The firm has invested in more than 180 companies across multiple sectors and raised over $11 billion in institutional capital. Headquartered in Boston, Massachusetts, USA, Spectrum has offices in San Francisco, California, and London, UK.
Splose Use of Funds
The company will use the funding to accelerate product development with deeper AI integration, expand in Australia and the UK, enhance payments infrastructure, and scale teams across multiple markets.
About Splose
Founded in 2018 by Nicholas Sanderson, Splose is a South Australian healthcare technology company that provides an AI-powered practice management platform for Allied Health professionals like physiotherapists, speech pathologists, and occupational therapists. Splose’s vertical SaaS platform offers an end-to-end operating system that streamlines bookings, case management, payments, invoicing, and business reporting. Headquartered in Adelaide, the platform serves over 20,000 professionals across Australia, the UK, and New Zealand.
Funding Details
Company: Splose
Raised: $46.0M AUD
Round: Series A
Funding Date: February 2026
Lead Investor: Spectrum Equity
Additional Investors: Athletic Ventures, EVP
Company Website: https://www.splose.com/
Software Category: HealthTech / Practice Management SaaS
Source: https://splose.com/resources/the-handover/splose-secures-landmark-46m-series-a-to-help-allied-health-practitioners